Aevi Genomic Medicine Inc (NASDAQ:GNMX)

1.54
Delayed Data
As of 12:37pm ET
 +0.01 / +0.65%
Today’s Change
0.98
Today|||52-Week Range
2.65
+28.33%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
AssetsCash33.3M53.1M39.8M33.7M
 
 
 
 
 
Short Term Investment Cash10.9M19.7M-13.2M-6.1M
 
 
 
 
 
Cash & Short Term Investments33.3M53.1M39.8M33.7M
 
 
 
 
 
 
ReceivablesReceivables315.0K0.000.000.00
 
 
 
InventoriesInventories0.000.000.000.00--
 
Current AssetsOther Current Assets0.00747.0K335.0K893.0K
 
 
 
 
Current Assets33.6M53.8M40.2M34.6M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross1.5M1.6M1.8M192.0K
 
 
 
 
 
Depreciation-1.0M-1.2M-1.4M-107.0K
 
 
 
 
 
Other Assets99.0K0.000.0043.0K
 
 
 
Total Assets34.3M54.3M40.6M34.8M
 
 
 
 
 
 
LiabilitiesAccounts Payable1.1M0.000.00943.0K
 
 
 
Accrued Expenses1.0M1.1M2.7M1.9M
 
 
 
 
 
Other Current Liabilities1.0M2.4M3.3M1.9M
 
 
 
 
 
Other Liabilities3.6M3.9M5.6M4.1M
 
 
 
 
 
 
Total LiabilitiesOther Liabilities980.0K0.000.000.00
 
 
Total Liabilities4.6M3.9M5.6M4.1M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity29.7M50.4M35.0M30.6M
 
 
 
 
 
Total Shareholder Equity29.7M50.4M35.0M30.6M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding24.8M32.9M37.1M59.3M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.